Aarey Drugs & Pharmaceuticals Ltd. - Research Center
524412 AAREYDRUGS Group (T) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Sales |
210.35 |
76.48 |
57.83 |
50.96 |
158.18 |
Operating profit |
-1.44 |
2.70 |
1.85 |
1.34 |
-2.18 |
Interest |
1.15 |
1.06 |
1.27 |
0.89 |
1.02 |
Gross profit |
2.55 |
1.94 |
1.42 |
1.14 |
2.35 |
EPS (Rs) |
0.77 |
0.40 |
0.31 |
0.29 |
0.14 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Other income |
5.14 |
0.29 |
0.84 |
0.70 |
5.54 |
Stock adjustment |
-7.76 |
-4.55 |
1.81 |
- |
-6.87 |
Raw material |
213.81 |
77.22 |
53.36 |
43.37 |
164.67 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
0.30 |
0.20 |
0.09 |
0.13 |
0.29 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
5.44 |
0.91 |
0.72 |
6.12 |
2.27 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.40 |
0.47 |
0.41 |
0.42 |
0.20 |
Taxation |
-0.01 |
0.44 |
0.22 |
- |
1.78 |
Net profit / loss |
2.15 |
1.02 |
0.78 |
0.72 |
0.36 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
28.05 |
25.38 |
25.38 |
25.38 |
25.38 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
-0.68 |
3.53 |
3.19 |
2.63 |
-1.38 |
GPM (%) |
1.18 |
2.52 |
2.42 |
2.21 |
1.43 |
NPM (%) |
1.00 |
1.33 |
1.34 |
1.40 |
0.22 |